VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 143 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $947,418 | +14.5% | 219,310 | +74.7% | 0.01% | +40.0% |
| Q2 2023 | $827,150 | +351.9% | 125,516 | +365.6% | 0.01% | +400.0% |
| Q1 2023 | $183,052 | -92.6% | 26,959 | -91.9% | 0.00% | -92.9% |
| Q4 2022 | $2,465,563 | +43.8% | 333,635 | +92.3% | 0.01% | +40.0% |
| Q3 2022 | $1,714,000 | +104.3% | 173,473 | +125.4% | 0.01% | +100.0% |
| Q2 2022 | $839,000 | -10.6% | 76,954 | -7.2% | 0.01% | -37.5% |
| Q1 2022 | $938,000 | -38.9% | 82,915 | -15.3% | 0.01% | -46.7% |
| Q4 2021 | $1,536,000 | +131.3% | 97,887 | +152.8% | 0.02% | +87.5% |
| Q3 2021 | $664,000 | -32.5% | 38,721 | -15.3% | 0.01% | -27.3% |
| Q2 2021 | $983,000 | -42.8% | 45,702 | -60.1% | 0.01% | -50.0% |
| Q1 2021 | $1,719,000 | +269.7% | 114,444 | +223.6% | 0.02% | +266.7% |
| Q4 2020 | $465,000 | -42.6% | 35,366 | -57.8% | 0.01% | -50.0% |
| Q3 2020 | $810,000 | -31.6% | 83,878 | -19.0% | 0.01% | -40.0% |
| Q2 2020 | $1,185,000 | +431.4% | 103,593 | +382.3% | 0.02% | +233.3% |
| Q1 2020 | $223,000 | -84.3% | 21,481 | -75.2% | 0.01% | -76.9% |
| Q4 2019 | $1,420,000 | +3.2% | 86,552 | -16.4% | 0.03% | -3.7% |
| Q3 2019 | $1,376,000 | +18.0% | 103,579 | +25.1% | 0.03% | +28.6% |
| Q2 2019 | $1,166,000 | -2.8% | 82,764 | +26.9% | 0.02% | -46.2% |
| Q1 2019 | $1,200,000 | +87.8% | 65,199 | +166.6% | 0.04% | +30.0% |
| Q4 2018 | $639,000 | -59.8% | 24,453 | -64.7% | 0.03% | -65.5% |
| Q3 2018 | $1,588,000 | +4311.1% | 69,211 | +2836.4% | 0.09% | +4250.0% |
| Q4 2017 | $36,000 | -92.1% | 2,357 | -90.7% | 0.00% | -92.0% |
| Q3 2017 | $454,000 | +251.9% | 25,387 | +221.3% | 0.02% | +212.5% |
| Q2 2017 | $129,000 | -34.2% | 7,902 | -43.6% | 0.01% | -42.9% |
| Q1 2017 | $196,000 | -3.9% | 13,999 | +9.7% | 0.01% | -12.5% |
| Q4 2016 | $204,000 | -16.7% | 12,764 | -13.2% | 0.02% | 0.0% |
| Q3 2016 | $245,000 | +28.3% | 14,705 | -13.4% | 0.02% | +60.0% |
| Q3 2015 | $191,000 | – | 16,976 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |